• Subscribe
  • Advertise
  • Contact Us
June 17, 2025
Pharma News HQ


  • Home
  • News
  • Clinical Trials
  • Drug Development
  • Manufacturing
  • Packaging and Labeling
  • Cold Chain
  • Diseases
  • Technology
  • Press Feed
    • Articles
    • Press Releases
  • Events
Top Headlines
  • [ February 14, 2023 ] Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues Manufacturing
  • [ February 14, 2023 ] Genenta Science signs manufacturing deal with AGC Biologics Manufacturing
  • [ February 14, 2023 ] Vial and Egnyte announce partnership for eTMF solution integration Clinical Trials
  • [ February 14, 2023 ] SOPHiA GENETICS and AstraZeneca partner for oncology drugs development Drug Development
  • [ February 14, 2023 ] FDA suggests ways to curb constraints with rare disease gene therapy trials Clinical Trials
Home2021

Year: 2021

Drug Development

AbCellera and Everest enter deal to discover antibody therapies

September 27, 2021 Pharma News HQ 0

AbCellera and Everest Medicines have signed a multi-year partnership and license agreement to discover therapeutic antibodies for up to ten targets selected by the latter. The collaboration will aid in growing Everest’s portfolio of new […]

Drug Development

Tonix and Columbia University to develop specialised Covid-19 vaccines

September 27, 2021 Pharma News HQ 0

The research partnership between Tonix Pharmaceuticals and Columbia University in the US has been extended to serve the development of Covid-19 vaccines and therapies precision treatment techniques. Additionally, Tonix Pharmaceuticals and Columbia University will analyse […]

Clinical Trials

J&J’s data confirms robust and durable protection of Covid-19 vaccine

September 27, 2021 Pharma News HQ 0

Johnson & Johnson (J&J) has reported the latest data confirming the robust and durable protection provided by its Janssen Covid-19 vaccine. The single-shot vaccine is authorised under a US Food and Drug Administration (FDA) Emergency […]

Clinical Trials

Oral molnupiravir has at least 350 patients left to recruit in Phase III Covid-19 trial

September 27, 2021 Pharma News HQ 0

The Phase III portion of an ongoing Phase II/III trial of Merck and Ridgeback Biotherapeutics’ molnupiravir in mild-to-moderate Covid-19 has enrolled around 1,100 to 1,200 patients of its 1,550-patient target, an investigator said. The trial […]

Press Releases

How has the PFS industry adapted to the shift towards connectivity and digital health

May 5, 2021 Pharma News HQ 0

SMi Reports: Now in its 8th year, the Pre-Filled Syringes East Coast virtual conference will bring together international industry experts in the field. We continue to witness significant growth and innovation in the pre-filled syringe […]

Posts pagination

« 1 … 14 15 16 … 19 »



















  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0
Pharma News HQ

Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.

 

About Us

 

Subscribe

 

Contact US

Latest Post
  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0